Skip to content

Calcium Autonomic Denervation Prevents Postoperative Atrial Fibrillation

Calcium Autonomic Denervation Prevents Postoperative Atrial Fibrillation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019276
Enrollment
Unknown
Registered
2018-11-02
Start date
2019-03-19
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

CaCl2 group:calcium autonomic denervation

Sponsors

Department of Cardiovascular Surgery, General Hospital of Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18=Aged=80 years; 2. Off-pump CABG surgery not in urgent or emergent situation and without IABP or inotropes for hemodynamic support before surgery; 3. EF>40%; 4. Patients undergoing heart surgery for the first time; 5. Good compliance and ability to complete follow-up.

Exclusion criteria

Exclusion criteria: 1. With history of AF; 2. Take class I or III anti-arrhythmic drugs; 3. With history of any type AF ablation operation; 4. With history of adult congenital heart disease or significant valvular disease; 5. With history of prior heart surgery; 6. Heart surgery is accompanied by other organ-system surgery; 7. Liver and kidney function abnormality (blood level exceed the upper limit of normal value by 3 times), or with surgical contraindications; 8. Patients suffering from other diseases who require radiotherapy, chemotherapy, and long-term hormone treatment; 9. Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Incidence of atrial fibrillation(lasting more than 30 seconds) during the first week of operation;

Secondary

MeasureTime frame
Days of hospital stay;Ventricular rate during AF;Inflammatory makers: PCT,IL-6, and hsCRP immediately after surgery;Actionable AF: antiarrhythmic use (including rate-control meds), CDV, anticoagulation, use of inotropes for BP support during AF;atrial fibrillation burden during the first week of operation;

Countries

China

Contacts

Public ContactHui-Shan Wang

Department of Cardiovascular Surgery, General Hospital of Northern Theater Command

huishanwang@hotmail.com+86 13309885095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026